These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6977222)

  • 1. T-cell growth factor (interleukin 2) control of T-lymphocyte proliferation: possible involvement in leukemogenesis.
    Gillis S; Mertelsmann R; Moore MA
    Transplant Proc; 1981 Dec; 13(4):1884-90. PubMed ID: 6977222
    [No Abstract]   [Full Text] [Related]  

  • 2. Restoration of allogeneic responsiveness of lymphocytes from cyclosporin A-treated animals with interleukin 2.
    Wang BS; Heacock EH; Zheng CX; Tilney NL; Mannick JA
    Transplantation; 1982 Apr; 33(4):454-6. PubMed ID: 6978560
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2.
    Cheever MA; Greenberg PD; Fefer A
    J Immunol; 1981 Apr; 126(4):1318-22. PubMed ID: 6970768
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.
    Metwali A; Blum A; Mathew R; Sandor M; Lynch RG; Weinstock JV
    Cell Immunol; 1993 Jun; 149(1):11-23. PubMed ID: 8099848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell recognition of Moloney sarcoma virus proteins. II. Phenotypes of the different lymphocyte subpopulations producing and responding to blastogenic factors and their relative frequencies during tumor regression.
    Lee JC; Enjuanes L; Cicurel L; Ihle JN
    J Immunol; 1981 Jul; 127(1):78-83. PubMed ID: 6972414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of B cell differentiation by T cell factors. I. Stimulation of IgM secretion by products of a T cell hybridoma and a T cell line.
    Puré E; Isakson PC; Takatsu K; Hamaoka T; Swain SL; Dutton RW; Dennert G; Uhr JW; Vitetta ES
    J Immunol; 1981 Nov; 127(5):1953-8. PubMed ID: 6975305
    [No Abstract]   [Full Text] [Related]  

  • 7. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
    Eberlein TJ; Rosenstein M; Spiess PJ; Rosenberg SA
    J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of macrophage subpopulations responsive to activation by endotoxin and lymphokines.
    Lee KC; Wong M; McIntyre D
    J Immunol; 1981 Jun; 126(6):2474-9. PubMed ID: 6971902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of human T cell colonies by an inducing activity (TCI) produced by normal human and malignant mouse cells.
    Gerassi E; Sachs L
    J Immunol; 1978 Dec; 121(6):2547-53. PubMed ID: 309906
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines.
    Stadler BM; Dougherty SF; Farrar JJ; Oppenheim JJ
    J Immunol; 1981 Nov; 127(5):1936-40. PubMed ID: 6975304
    [No Abstract]   [Full Text] [Related]  

  • 12. A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor.
    Schrader JW; Clark-Lewis I
    J Immunol; 1982 Jul; 129(1):30-5. PubMed ID: 6979567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subclone of the CEM cell line produces human B cell growth factor activity.
    Ligler FS
    Lymphokine Res; 1984; 3(4):183-91. PubMed ID: 6333568
    [No Abstract]   [Full Text] [Related]  

  • 14. Polyclonal activation of rat T lymphocytes by RT6 alloantisera.
    Wonigeit K; Schwinzer R
    Transplant Proc; 1987 Feb; 19(1 Pt 1):296-9. PubMed ID: 3493556
    [No Abstract]   [Full Text] [Related]  

  • 15. Concomitant increase in antigen binding and in T cell membrane lipid viscosity induced by the lymphocyte-activating factor, LAF.
    Puri J; Shinitzky M; Lonai P
    J Immunol; 1980 Apr; 124(4):1937-42. PubMed ID: 6988510
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
    Frank MB; Watson J; Mochizuki D; Gillis S
    J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
    Maeda H; Ogoshi S; Fujimoto S
    Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-2 promotes antigenic reactivity of rested T cells but prolongs the postactivational refractory phase of activated T cells.
    Norris MS; McConnell TJ; Mannie MD
    Cell Immunol; 2001 Jul; 211(1):51-60. PubMed ID: 11585388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting proliferation of nonimmune murine T cells in vitro.
    Zhou P; Quackenbush LJ; Gorzynski TJ; Thacore H; Dowjat WK; Akinbami C; Zaleski MB
    Transplant Proc; 1989 Feb; 21(1 Pt 1):171-3. PubMed ID: 2784890
    [No Abstract]   [Full Text] [Related]  

  • 20. A lymphocyte growth factor made by a human lymphoid cell line.
    Sanderson R; Vesole D; Jakway J; Talmage D
    Immunol Rev; 1980; 51():177-91. PubMed ID: 7000670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.